Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Trading Statement

29 Jan 2024 07:00

RNS Number : 1119B
Croma Security Solutions Group PLC
29 January 2024
 

29 January 2024

Croma Security Solutions Group Plc

("CSSG", "Croma", "the "Company" or the "Group")

Trading Statement and NHS Trust Contract Renewal

Croma Security Solutions Group plc (AIM:CSSG) is pleased to announce the following positive update on trading for the six months to 31 December 2023, as well as a three year NHS Trust contract renewal.

The Company has delivered a solid first half performance and is expecting to report in line with management expectations with revenue of £4.28 million (HY22: £3.77 million excludes non-continuing businesses) an increase of 13.5% on the equivalent period last year.

Following a competitive tender process, Croma was re-awarded a three-year maintenance contract by an NHS Trust to cover the security needs of their hospitals. This is one of a number of health sector clients for Croma where we have achieved a high level of service and client specific understanding making Croma a very competitive provider of security services in this sector.

As announced on 8 January, 2024 began positively with the acquisitions of two profitable locksmith businesses, for a combined cash consideration of £438,000 which includes a freehold property valued at £0.35 million. The two locksmith businesses have a combined annual turnover of £0.5 million and operate from Peterborough and Worthing, extending the number and geography of the Group's existing network. The two business are integrating well into the Group, bringing the total number of Croma stores to 16.

The acquisitions are part of the Group's ambitions to roll out its security centre network nationwide utilising the Group existing cash resources and future receipts from the sale of Vigilant. There are further acquisition opportunities under consideration by the management team with the potential to transform more traditional locksmiths into modern security centres with stronger in-store product ranges and much greater profit potential.

The Company expects to report its interim results for the six months ended to 31 December 2023 in March 2024.

Roberto Fiorentino, Chief Executive Officer, commented: "The Croma Group continues to progress well, delivering a good sales performance in the first six month of our financial year despite the turbulent economic landscape and downturn experienced by so many business sectors. It is also encouraging to have already secured two additional locksmith stores in the second half of the year. Furthermore, the retention of the NHS contract reflects well on our business and the services we have delivered to date, and I am looking forward to continuing our relationship with the hospitals. Our strategy continues to deliver, and I am confident that our interim results will bring further proof of this."

 

 

For further information visit www.cssgplc.com or contact:

 

Croma Security Solutions Group Plc ?Tel: +44 44 (0)1489 566 166

Roberto Fiorentino, CEO

Teo Andreeva, CFO

 

WH Ireland Limited ?Tel: +44 (0)207 220 1666

(Nominated Adviser and Broker)

Mike Coe

Sarah Mather

 

Novella Tel: +44 (0)203 151 7008

Tim Robertson

Claire de Groot

Safia Colebrook

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDBLGDDGSL
Date   Source Headline
16th Mar 20267:00 amRNSAcquisition
16th Mar 20267:00 amRNSAcquisition
26th Feb 20267:00 amRNSHalf-year Financial Report
23rd Feb 20264:58 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSNotice of Results
15th Jan 20268:32 amRNSDirector Dealing
5th Jan 20267:00 amRNSAcquisition
1st Dec 202511:30 amRNSResult of AGM
25th Nov 20257:00 amRNSNotice of AGM
3rd Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results and Investor Presentation
23rd Oct 20257:00 amRNSDirectorate Change
5th Sep 20251:59 pmRNSBoard Change
2nd Sep 20253:29 pmRNSBoard Change
16th Jul 202511:19 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Statement
8th May 20253:55 pmRNSDirector/PCA Dealings
25th Apr 20256:10 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAcquisition
6th Mar 20257:00 amRNSGrant of Options
24th Feb 20257:00 amRNSHalf-year Report
19th Feb 20257:00 amRNSNotice of Results and Investor Presentations
3rd Feb 20257:00 amRNSAcquisition
20th Jan 20257:00 amRNSTrading Statement
4th Dec 20249:26 amRNSResult of AGM
4th Dec 20247:00 amRNSAGM Statement
28th Nov 20247:00 amRNSNotice of AGM
5th Nov 202411:10 amRNSDirector Dealing
5th Nov 20247:00 amRNSNotice of Investor Presentation
4th Nov 20247:00 amRNSFinal Results
29th Oct 20242:38 pmRNSDirector/PCA Dealings
14th Aug 20247:00 amRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTrading Statement
15th Jul 20247:00 amRNSChange of Adviser
8th Jul 20247:00 amRNSReceipt of Deferred Consideration
3rd Apr 20247:00 amRNSNHS Contract Win
21st Feb 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNSTrading Statement
8th Jan 20247:00 amRNSAcquisition
1st Dec 202310:24 amRNSResult of AGM
16th Nov 20237:00 amRNSNotice of AGM
13th Nov 202312:54 pmRNSDirector Dealing
13th Nov 20237:00 amRNSGrant of Options
8th Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFinal Results
26th Oct 20232:42 pmRNSTransaction in own shares and total voting rights
26th Oct 20237:00 amRNSTransaction in own shares and total voting rights
8th Aug 202310:17 amRNSHolding(s) in Company
7th Aug 202311:10 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.